CIBC Asset Management
ONC

CIBC Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

CIBC Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-954
Closed -$258K – 1612
2021
Q4 		$258K Sell
954
-90
-9% -$30.4K ﹤0.01% 1182
2021
Q3 		$379K Buy
1,044
+61
+6% +$19.9K ﹤0.01% 907
2021
Q2 		$337K Buy
983
+28
+3% +$9.27K ﹤0.01% 939
2021
Q1 		$332K Buy
+955
New +$316K ﹤0.01% 923
2020
Q4 		– Sell
-3,237
Closed -$927K – 1270
2020
Q3 		$927K Buy
3,237
+250
+8% +$58.8K ﹤0.01% 604
2020
Q2 		$563K Buy
2,987
+289
+11% +$47K ﹤0.01% 664
2020
Q1 		$332K Buy
2,698
+132
+5% +$20.6K ﹤0.01% 713
2019
Q4 		$425K Buy
2,566
+331
+15% +$55K ﹤0.01% 767
2019
Q3 		$274K Buy
2,235
+116
+5% +$15.4K ﹤0.01% 873
2019
Q2 		$263K Sell
2,119
-63
-3% -$8K ﹤0.01% 909
2019
Q1 		$288K Buy
2,182
+54
+3% +$7.29K ﹤0.01% 855
2018
Q4 		$298K Buy
+2,128
New +$282K ﹤0.01% 784

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

CIBC Asset Management's ONC Position: Q1 2022 in Review

CIBC Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 954 shares — an estimated $258K sold.

CIBC Asset Management first reported a position in ONC in Q4 2018 and held it in 12 quarters. The position peaked at $927K in Q3 2020. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • CIBC Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • CIBC Asset Management sold 954 BeOne Medicines Ltd shares in Q1 2022, an estimated $258K.
  • CIBC Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 12 quarters.
  • CIBC Asset Management's BeOne Medicines Ltd position peaked at $927K in Q3 2020.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on CIBC Asset Management's 13F filing for Q1 2022, filed 6 May 2022.